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Abstract
Aneuploidy represents the most prevalent form of genetic instability found in human embryos and is the leading genetic
cause of miscarriage and developmental delay in newborns. Telomere DNA deficiency is associated with genomic instability
in somatic cells and may play a role in development of aneuploidy commonly found in female germ cells and human
embryos. To test this hypothesis, we developed a method capable of quantifying telomere DNA in parallel with 24-
chromosome aneuploidy screening from the same oocyte or embryo biopsy. Aneuploid human polar bodies possessed
significantly less telomere DNA than euploid polar bodies from sibling oocytes (23.07 fold, P=0.016). This indicates that
oocytes with telomere DNA deficiency are prone to aneuploidy development during meiosis. Aneuploid embryonic cells
also possessed significantly less telomere DNA than euploid embryonic cells at the cleavage stage (22.60 fold, P=0.002) but
not at the blastocyst stage (21.18 fold, P=0.340). The lack of a significant difference at the blastocyst stage was found to be
due to telomere DNA normalization between the cleavage and blastocyst stage of embryogenesis and not due to
developmental arrest of embryos with short telomeres. Heterogeneity in telomere length within oocytes may provide an
opportunity to improve the treatment of infertility through telomere-based selection of oocytes and embryos with
reproductive competence.
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Introduction
Gain or loss of an entire chromosome (aneuploidy) is the most
common genetic cause of miscarriage and developmental delay in
humans. Advanced maternal age is a well known risk factor and a
reflection of the observation that aneuploidy primarily arises
during meiosis of the maternal gamete, the oocyte [1]. It is also
well established that a decline in fertility occurs as maternal age
increases. Therefore, as women continue to delay their childbear-
ing into the mid to late thirties, there has been a growth in the
utilization of preimplantation genetic screening (PGS) to avoid
aneuploid conceptions during the in vitro fertilization (IVF)-based
treatment of infertility. PGS of aneuploidy has recently advanced
to include the ability to screen for all 24 chromosomes [2–4] has
revealed that aneuploidy of any and all chromosomes found in
humans can be present at the preimplantation stages of human
embryonic development [5].
A number of events have been proposed to play a role in the
development of aneuploidy during maternal meiosis of the oocyte.
These include inappropriate or lack of formation of chiasmata,
which link homologous chromosomes to ensure proper alignment
[6], and late exit from the production line of oogenesis [7]. More
recently, telomere dysfunction has been proposed as a phenom-
enon that unifies these and other events and as a general
explanation for female reproductive senescence [8]. Indeed, the
role of telomeres in maintaining chromosome stability was
proposed over 70 years ago [9] and many studies have since
demonstrated that excessive telomere shortening results in
chromosome instability in somatic cells [10]. An animal model
of telomere deficiency has also illustrated the importance of
telomeres in germ cell chromosome stability [11–13]. In 4
th
generation telomerase knockout mice, oocytes develop abnormal
spindles. Since spindle formation is a critical event in proper
chromosome segregation, this observation suggests that telomeres
may play a role in the development of oocyte aneuploidy in the
human. However, the prevalence of aneuploidy as a result of
spindle formation defects in the telomerase knockout oocytes or
ensuing embryos has not been specifically measured. In addition,
artificially inducing telomere shortening through genetic deletion
of the telomerase gene in mice may not reflect naturally occurring
events in human oogenesis or embryogenesis.
In order to directly investigate whether telomere DNA is
associated with development of aneuploidy in the preimplantation
stages of human development, one must address several
limitations. These include studying low quantities of DNA,
obtaining access to normal human ooctyes and embryos, and
developing the ability to simultaneously quantify telomere DNA
and comprehensively diagnose aneuploidy from the same oocyte
or embryo biopsy. The present study represents the first
opportunity to overcome these hurdles. Much of this opportunity
is related to the recent development of an accurate single cell SNP
microarray based 24-chromosome aneuploidy screening method-
PLoS Genetics | www.plosgenetics.org 1 June 2011 | Volume 7 | Issue 6 | e1002161ology [2]. Since this technique involves the use of whole genome
amplification (WGA), excess DNA is available to simultaneously
quantify telomere DNA. Moreover, since SNP microarray based
24-chromosome aneuploidy screening has been employed in a
number of Institutional Review Board approved clinical trials
[3,4], DNA from the highest quality (normal) IVF derived human
oocytes and embryos is also available for analysis of telomere
DNA. Therefore, the objectives of the present study were to first
validate a method to simultaneously assess 24 chromosome
aneuploidy and telomere DNA content from human oocytes and
embryos and then to test the hypothesis that telomere DNA
content is associated with development of human embryonic
aneuploidy.
Results
Validation of relative telomere DNA quantitation after
whole-genome amplification (WGA)
A novel assay was developed and evaluated for the ability to
accurately quantify relative amounts of telomere DNA from single
or few cells after WGA. This was important to demonstrate the
reliability of using existing 24-chromosome aneuploidy screened
WGA DNA from oocyte and embryo biopsies. A multicopy Alu-
Ya5 sequence was targeted as an endogenous control for telomere
DNA quantity in order to accommodate differences in the number
of input cells, the presence of aneuploidy, or possible single cell
single locus PCR drop out within the reference and test samples.
As expected, real-time PCR products using previously published
primers for telomere DNA [14], and SYBR Green-based
detection, displayed a single peak upon dissociation curve analysis
(Figure 1A). This confirmed sequence specificity of amplification
from both isolated genomic DNA and whole genome amplified
DNA. In addition, the relative telomere DNA quantity observed in
isolated genomic DNA and whole genome amplified DNA of
various cell lines was similar to values calculated from the reported
literature [15–19] (Figure 1B). Most importantly, the Pearson
correlation (r
2) between experimentally determined relative
telomere DNA quantities from isolated genomic DNA and whole
genome amplified DNA from the same cell lines was 0.97,
indicating that WGA faithfully represents the relative quantities of
telomere DNA found in the original sample.
Relative telomere DNA length in aneuploid and euploid
polar bodies
A total of 18 polar bodies (9 euploid and 9 aneuploid) from 9
IVF patients were evaluated for telomere DNA length (Table 1).
The patient-specific variable of maternal age of the oocyte was
controlled for by conducting paired analyses of telomere DNA
quantity in sibling aneuploid and euploid polar body biopsies from
oocytes derived from the same patient and IVF treatment cycle.
Examples of results of aneuploidy screening are shown in
Figure 2A. Aneuploid polar bodies displayed significantly lower
quantities of telomere DNA than paired sibling euploid polar
bodies (23.04 fold, P=0.016, Figure 3).
Relative telomere DNA length in aneuploid and euploid
blastomeres
A total of 24 blastomeres (14 euploid and 10 aneuploid) from 9
IVF patients were evaluated. Each patient provided at least one
euploid and one aneuploid blastomere for paired analysis of
relative telomere DNA length in sibling embryos (Table 2).
Examples of results of aneuploidy screening are shown in
Figure 2B. Again, all patient specific variables were controlled
by comparing an aneuploid blastomere to a euploid blastomere
from sibling embryos derived from the same patient and IVF
treatment cycle. Samples were also evaluated by paired analysis for
differences in embryo fragmentation, cell number, and morpho-
logical grade. Morphological characteristics were not significantly
different between sibling aneuploid and euploid embryos in this
study (Table 2). Photographs of each of the cleavage stage embryos
included in this study are also shown in Figure 2C. Aneuploid
blastomeres displayed significantly reduced telomere DNA
quantity relative to their paired sibling euploid blastomeres
(22.6 fold, P=0.002, Figure 3).
Relative telomere DNA length in aneuploid and euploid
trophectoderm
A total of 20 trophectoderm biopsies from sibling blastocyst
stage embryos (10 aneuploid and 10 euploid) from 10 IVF patients
were evaluated (Table 3). Examples of results of aneuploidy
screening for each of the trophectoderm samples are shown in
Figure 2D. In addition to controlling for maternal and paternal
age by sibling paired analysis of telomere DNA quantity, embryo
morphology was controlled for by selecting samples with identical
morphological grade [20] within each pair of blastocysts (Table 3).
Aneuploid blastocyst trophectoderm displayed quantities of
telomere DNA that were not significantly different from their
sibling euploid blastocysts (P=0.340, Figure 3).
Telomere DNA elongation during human embryogenesis
One mechanism by which aneuploid blastocysts may develop
telomere DNA length equivalent to the length observed in euploid
blastocysts is through telomere DNA elongation between the
cleavage and blastocyst stages of development (Figure 4A). This
phenomenon has been observed in animals [21,22] and recently
by unpaired analysis in humans [23]. Telomere DNA was
quantified in the 1
st and 2
nd polar body and a blastomere from
each of 21 cleavage stage embryos, and in the 1
st and 2
nd polar
body and a trophectoderm biopsy from each of 29 blastocyst stage
Author Summary
Human eggs (oocytes) are exceptionally prone to the
erroneous acquisition of too few (monosomy) or too many
(trisomy) chromosomes during development (meiosis). In
fact, this type of instability, termed aneuploidy, represents
the most common genetic cause of miscarriage in
pregnant women (i.e. trisomy 16) and developmental
delay in newborns (i.e. Down syndrome from trisomy 21).
Although aneuploidy has become a growing problem for
women as they delay childbearing into the late thirties, the
underlying molecular etiology remains unknown. Since
telomere DNA is known to protect the ends of chromo-
somes from degradation during cell division and is
associated with aneuploidy in cancer cells in adults, we
tested whether telomere DNA plays a role in aneuploidy
development in human oocytes and embryos (where
aneuploidy is much more common). We demonstrate that
telomere DNA deficiency is indeed associated with
aneuploidy in oocytes and early preimplantation (cleav-
age) stage embryos. This association is reversed upon
development to late preimplantation (blastocyst) stage
embryos as a result of telomere DNA elongation. These
results indicate that telomere DNA deficiency may cause
inappropriate chromosome segregation during human
oocyte cell division (meiosis) and may serve as a marker
for oocytes and embryos that lack the ability to produce
healthy children.
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PLoS Genetics | www.plosgenetics.org 2 June 2011 | Volume 7 | Issue 6 | e1002161Figure 1. Valdiation of a novel assay for telomere DNA relative quantitation from limited amounts of starting material. (A) The
telomere DNA assay amplification product produced a single peak upon dissociation curve analysis demonstrating specificity on purified genomic (g)
DNA from a large quantity of cells, and from whole genome amplified (WGA) DNA from picogram quantities of purified gDNA. (B) Quantities of
telomere DNA in various cancer cell lines relative to MCF-7 cells either reported in the literature or determined with the assay developed in this study.
In each case, the Pearson correlation coefficient (R
2) of the relative quantitation profiles are shown and illustrate the maintenance of relative
abundance after characterization of picogram quantities of starting material.
doi:10.1371/journal.pgen.1002161.g001
Table 1. Polar body samples evaluated by microarray based aneuploidy screening and relative telomere DNA quantitation.
Patient # Maternal Age sample type Oocyte # Aneuploidy Oocyte # Aneuploidy
telDNA fold
change
1 32.2 PB2 1 217 2 normal 0.44
2 41.3 PB2 1 214,+16,+18 2 normal 0.04
3 34.5 PB2 1 215 2 normal 1.02
4 36.2 PB2 1 +18 2 normal 0.09
5 33.3 PB2 1 216 2 normal 0.69
6 41.3 PB1 1 218,+21 2 normal 0.42
7 40.6 PB1 1 222 2 normal 1.01
8 39.5 PB1 1 215,216 2 normal 0.32
9 33.3 PB1 1 +3,+7,+17 2 normal 0.32
Mean6SEM 0.4360.12.
doi:10.1371/journal.pgen.1002161.t001
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embryo biopsies were found to be euploid. Telomere DNA in each
2
nd polar body and each embryo biopsy was evaluated relative to
the 1
st polar body that was derived from the same oocyte
(Figure 4B). No significant differences in levels of telomere DNA
were observed in 1
st or 2
nd polar bodies derived from the same
oocyte (1.5-fold, P=0.71, and 1.2-fold, P=0.32, respectively). In
addition, telomere DNA in blastomeres from cleavage stage
embryos was not significantly different from levels found in the
corresponding 1
st polar body (2.0-fold, P=0.14). However,
telomere DNA in trophectoderm biopsies from blastocyst stage
embryos displayed a significant increase in quantity relative to the
corresponding 1
st polar body (5.7-fold, P=5.5610
210). These
results indicate that telomere DNA is elongated during develop-
ment between the cleavage and blastocyst stage of development in
the human.
Relative telomere DNA length in developmentally
arrested and competent embryos
Another mechanism by which aneuploid blastocysts may
develop telomere DNA length equivalent to the length observed
in euploid blastocysts is through developmental selection
(Figure 4A). For this mechanism to be true, one would expect
that embryos which fail to progress to the blastocyst stage
(developmental arrest) would also possess significantly reduced
telomere DNA length relative to embryos which successfully
develop to the blastocyst stage (developmentally competent).
Forty-four paired analyses of developmentally arrested and
competent embryos, that were otherwise developmental stage
and ploidy matched, were evaluated for relative telomere DNA
quantity (Figure 4C). A significant difference in telomere DNA
length between arrested and developmentally competent embryos
was not observed (P=0.29). This result indicates that aneuploid
blastocysts do not develop levels equivalent to euploid blastocysts
through selection against embryos with short telomeres.
Discussion
An accurate method for simultaneous relative quantitation of
telomere DNA content and 24 chromosome aneuploidy screening
in single cells was developed. Key features of this assay include the
use of a multicopy endogenous control target sequence to prevent
differences in the number of cells, nuclear DNA content (haploid
bivalent, haploid univalent, diploid), the presence of aneuploidy,
or single locus drop out from impacting the relative quantitation of
telomere DNA in the test and reference samples. The use of a
multicopy gene for normalization may also help to avoid issues
with amplification bias from single cells since it represents an
abundant target within the single cell and would be less susceptible
to the well characterized single locus bias that is found after
applying WGA [24]. The same concept may be true when
applying WGA based amplification to evaluate telomere DNA
since it also represents a multicopy sequence. It was also important
to utilize DNA processing specific relative quantitation since an
apparent decrease in telomere DNA content relative to the total
amount of DNA was observed after whole genome amplification
(mean DCT of 22.561.3) compared to isolated genomic DNA
(mean DCT of 12.960.6) from the same cell lines. In addition, the
paired nature of the relative quantitation was also important. For
example, the paired sample study design controlled for all patient
specific variables that may be associated with telomere DNA
content including maternal age, paternal age, and genetic
background. Paired analysis may also be important to avoid
potential issues related to the use of the Alu-Ya5 sequence when
normalizing telomere DNA content measurements since different
individuals in a given population may possess natural variations in
Alu-Ya5 copy number. The paired-sample design also controls for
all unknown patient specific variables inherent in any study
involving humans.
In addition to controlling for differences that may be attributed
to patient specific variables, this study also controlled for
morphological characteristics of cleavage and blastocyst stage
embryos. This was important since previous work indicated that
embryo fragmentation was predictive of telomere DNA quantity
[25]. The present study established that pairs of euploid and
aneuploid samples were either not significantly different (cleavage
stage) or specifically selected to have been given identical
morphological grades (blastocyst stage). With these parameters
controlled within each paired analysis, significant difference in
telomere DNA quantity was observed between the aneuploid and
euploid polar bodies and cleavage stage blastomeres but not
trophectoderm from the blastocyst. The correction of telomere
DNA length through elongation between the cleavage and
Figure 2. Example results of SNP microarray based 24 chromosome aneuploidy screening in human oocytes and preimplantation
embryos that were also characterized for telomere DNA content. (A) SNP microarray based chromosome specific copy number graphs of
euploid and aneuploid sibling polar bodies from polar body specific patients 2, 5, 8, and 9 (Table 1). (B) SNP microarray based copy number graphs of
euploid and aneuploid sibling blastomeres from blastomere specific patients 5, 6, 7, and 9 (Table 2). (C) Photographs of cleavage stage sibling
embryos from the 9 blastomere specific patients analyzed in the present study (Table 2). (D) SNP microarray based copy number graphs of euploid
and aneuploid sibling blastocyst stage embryos from trophectoderm specific patients 1, 7, 8, and 9 (Table 3).
doi:10.1371/journal.pgen.1002161.g002
Figure 3. Mean quantities (±SEM) of telomere DNA found in
aneuploid relative to euploid polar bodies, blastomeres, and
trophectoderm biopsies. P-values from paired analysis of sibling
samples within each patient are shown and illustrate the significant
decrease in relative quantity in aneuploid polar bodies and blastomeres
but not trophectoderm.
doi:10.1371/journal.pgen.1002161.g003
Telomere Deficiency in Aneuploid Embryos
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Similar findings were obtained in animal studies [21,22] and in a
recent study involving unpaired analyses of human embryos [23].
Most importantly, results of the present study demonstrate that
telomere DNA length is associated with human aneuploidy
development for the first time. The correlation between telomere
length and aneuploidy during embryogenesis also corresponds
with the previously identified and predominantly maternal meiotic
origin of aneuploidy [1], and with recent observations of genomic
instability at the cleavage stage of development [26]. Interestingly,
the relationship between telomere content and aneuploidy was
maintained when embryonic cells were evaluated at the cleavage
stage of development despite the presence of both maternal and
paternal chromosome telomere DNA. However, the extent to
which telomere content was decreased in aneuploid cleavage stage
embryonic cells was slightly lower than that observed in polar
bodies from the oocyte (Figure 3), which is consistent with the
maternal origin of aneuploidy. Future studies may need to focus
on whether there is an association between telomere DNA content
and the cell division and parental specific origins of aneuploidy.
This will require development of the ability to predict origins of
aneuploidy in single cell quantities of DNA in a manner similar to
that described for analysis of large quantities of DNA from
products of conception [27]. Although rare, it is possible for
compensation of meiosis I errors derived from premature
separation of sister chromatids (PSSC) to lead to a euploid oocyte
by segregation of the abnormality to the 2
nd polar body [28].
However, all the aneuploid polar bodies evaluated in this study
were only from oocytes which led to aneuploid embryos. Future
studies might include evaluating whether decreased telomere
length is differentially associated with aneuploidy from PSSC
compared to nondisjunction.
Since reduced recombination remains one of the well known
risk factors in nondisjunction and development of aneuploidy in
humans [6], the strong association between telomere length and
aneuploidy in oocytes and cleavage stage embryos in the present
study might be the result of reduced meiotic recombination and
impaired chromosome pairing and synapsis that have been
observed in oocytes from telomere deficient mice [12]. In support
of this is the observation that the decrease in oocyte telomere
Figure 4. Telomere DNA in aneuploid blastocysts. (A) Diagram illustrating two potential mechanisms by which aneuploid blastocysts could
obtain normalized quantities of telomere DNA. (B) Results of testing the potential for ‘‘correction’’ to explain normalized quantities of telomere DNA
in aneuploid blastocysts. A significant increase (P,0.05) was found in telomere DNA quantity in trophectoderm from blastocysts relative to the 1
st
polar body from the same oocyte. A significant increase was not found in blastomeres from cleavage stage embryos. This suggests that telomere
DNA is reset between the cleavage and blastocyst stage of embryogenesis in humans. (C) Results of testing the potential for ‘‘selection’’ to explain
normalized quantities of telomere DNA in aneuploid blastocysts. Significance was not reached when comparing sibling arrested and developmentally
competent embryos (P=0.29). This suggests that embryos with short telomeres aren’t more prone to developmental arrest between the cleavage
and blastocyst stage of embryogenesis in humans.
doi:10.1371/journal.pgen.1002161.g004
Table 3. Trophectoderm samples evaluated by microarray based aneuploidy screening and relative telomere DNA quantitation
(aneuploid versus euploid).
Patient # Maternal Age Embryo no. Grade Aneuploidy Embryo no. Grade Aneuploidy
telDNA Fold
Change
1 32.3 1 4AA normal 2 4AA 45,XY,216 1.04
2 38.4 1 5BB normal 2 5BB 47,XY,+16 0.84
3 39.5 2 4BB normal 1 4BB 45,XY,211,220,+21 0.97
4 34.3 1 4BB normal 2 4BB 47,XX,+15 0.72
5 31.9 2 5BB normal 1 5BB 47,XX,+15 0.99
6 42.3 2 5AA normal 1 5AA 47,XY,+9,+17,220 0.22
7 31.9 1 5BB normal 2 5BB 47,XX,+15 1.25
8 33.4 2 5BB normal 1 5BB 45,XX,215 1.51
9 40.0 2 4BB normal 1 4BB 48,XX,+2,+16 0.92
10 35.7 1 5BB normal 2 5BB 45,XY,215 0.82
Mean±SEM 0.93±0.11.
doi:10.1371/journal.pgen.1002161.t003
Telomere Deficiency in Aneuploid Embryos
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oocytes was approximately 0.4-fold (20/50, as displayed in figure
5b of reference [12]), similar to the decrease of 0.43-fold observed
in aneuploid relative to euploid polar bodies in the present study
(Figure 3). Some studies also suggest that telomeres are directly
involved in homologous chromosome pairing where synapsis may
begin at the telomeres [29]. Further investigation into whether
polar bodies and embryos with decreased telomere length also
possess reduced numbers of recombination events may help
support these findings.
The observation that heterogeneity in telomere DNA content
exists within oocytes and embryos derived from a single controlled
ovarian stimulation (COS) cycle may represent a phenomenon
relevant to improving reproductive medicine. If reduced telomere
DNA length represents an intermediate event that precedes
aneuploidy development, then telomere length may represent a
useful marker of embryonic reproductive potential. Given the
recent evidence that not all euploid embryos possess reproductive
potential, that the age related decline in fertility is not entirely due
to aneuploidy [3], and the results of the present study, further
investigation into the predictive value of telomere DNA length for
ovarian reserve and reproductive potential and senescence using
the methods developed in this study is warranted.
Materials and Methods
Ethics statement
This study was conducted under Institutional Review Board
approval from Western IRB (Olympia, WA) and with informed
patient consent.
Relative telomere measurement by quantitative real-time
PCR
Telomere DNA was amplified using ‘‘telg’’ and ‘‘telc’’ primers
previously described by Cawthon et al [14] at a final concentration
of 900 nM each. SYBR Green PCR Master Mix (Applied
Biosystems Inc., Foster City, CA) was used at the manufacturer’s
recommended concentration. In order to normalize input DNA,
primers and a TaqMan probe for the multicopy Alu (Ya5 family)
sequence were used as previously described [30] but with use of a
FAM dye instead of VIC (Applied Biosystems Inc.). A multicopy
gene for normalization was used to avoid potential issues with a
single copy gene locus dropout from single cell WGA, and the
potential impact of aneuploidy on single copy gene copy number.
TaqMan Alu primers and probe, and TaqMan Gene Expression
Master Mix were used at the manufacturer’s recommended
concentrations (Applied Biosystems Inc.). Both the telomere DNA
SYBR Green and Alu DNA TaqMan assay reactions were
performed in quadruplicate for each template DNA and in a final
reaction volume of 5 ml in a MicroAmp Optical 384-Well
Reaction Plate (Applied Biosystems Inc.). Five ng of genomic
DNA or 10 ng of WGA DNA template was used in each reaction.
A 7900HT SDS real-time PCR instrument (Applied Biosystems
Inc.) was used with the default cycling conditions and dissociation
curve settings in the instrument control and data acquisition
software (SDS version 2.3, Applied Biosystems Inc.). The default
settings of RQ Manager version 1.2 data analysis software
(Applied Biosystems Inc.) were used to assign a threshold cycle
number to each reaction. Results were exported to Excel
(Microsoft Inc., Redmond, WA) for statistical analysis.
Cell line DNA standards for assay validation
MCF-7, HeLa, A431,Jurkat, and K562 cell line isolatedgenomic
DNA was obtained from BioChain Inc. (Hayward, CA) and the
expected telomere DNA length was estimated from previous reports
[15–19]. More specifically, the average length in kilobases (kb)
reported for each cell line was used as the numerator (i.e.
A431=3.0 kb; K562=6.5 kb; HeLa=9.0 kb; and Jur-
kat=11.5 kb), and the average length in the MCF-7 cell line was
used as the denominator to calculate a ratio (relative fold change
quantity). The resulting relative fold change quantities served as a
reference for analysis using the assay developed in the present study.
Whole genome amplification (WGA) was performed on 35 pico-
gramsofgenomicDNAusingaGenomePlexSingleCellWGA4Kit
accordingtothemanufacturer’sinstructions(SigmaAldrichInc.,St.
Louis, MI). WGA DNA was purified using GenElute PCR
purification kit according to the manufacturer’s instructions (Sigma
Aldrich Inc.).PurifiedWGADNAwasquantifiedusinga Nanodrop
8000 spectrophotometer (Nanodrop Inc., Wilmington, DE).
Relative quantitation (fold change) of telomere DNA content
was determined using the comparative CT method [31] with
telomere DNA representing the ‘‘gene of interest’’ and Alu DNA
representing the ‘‘internal control’’ (i.e. telomere DNA CT2Alu
DNA CT=DCT). Cell line telomere DNA DCT values were
evaluated with the MCF-7 cell line DCT as the reference control.
Pearson correlation coefficients were calculated for fold change
values experimentally determined from either genomic DNA
(n=4) or WGA DNA (n=4) with respect to the expected fold
change values calculated from telomere DNA lengths reported in
the literature [15–19]. A Pearson correlation coefficient was also
calculated for experimentally determined genomic DNA with
respect to WGA DNA. It should be noted that the assay developed
in this study cannot be used to determine an absolute measure of
telomere length such as might be represented in kb units. The
assay is only capable of determining the relative quantity of
telomere DNA in one sample compared to another (fold change).
Aneuploid and euploid polar body and embryo biopsy
DNA for telomere quantitation
DNA from human polar bodies and embryo biopsy WGA was
obtained as previously described [32,33], and used for analysis of
telomere DNA content. All samples were obtained under
Institutional Review Board approval (WIRB, Olympia, WA) and
with informed patient consent. Samples were specifically selected
from cases where both an aneuploid and a euploid 1
st polar body,
2
nd polar body, or embryo biopsy WGA DNA sample was
available from the same patient and IVF treatment cycle, and
from embryos with similar morphology (cell number, fragmenta-
tion, and grade), in order to allow for paired analysis. All polar
bodies were biopsied from oocytes that led to embryos suitable for
transfer by conventional morphological assessment. Euploid polar
bodies used in this study were always associated with oocytes in
which both the 1
st and 2
nd polar body was euploid. Likewise,
aneuploid polar bodies used in this study were always associated
with oocytes which produced an aneuploid embryo.
Euploid embryo or polar body DCT values were used as the
reference control for aneuploid embryo or polar body DCT values
in patient specific pairs. Confirmation of normal distribution of
aneuploid or euploid embryo or polar body telomere DNA
quantities was evaluated by performing a Shapiro-Wilk W test.
Telomere DNA length (DCT) in polar bodies, blastomeres,
trophectoderm biopsies, and arrested embryos was compared for
significance using a paired Student’s t-test. Blastocyst stage embryo
morphology was controlled by selecting samples with identical
morphological grade [20] within each patient specific pair.
Aneuploid and euploid cleavage stage embryo telomere DNA
length (DCT) was compared using a mixed linear model with fixed
effects terms from telomere DNA length (DCT) versus ploidy state,
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variability. Cleavage stage embryo telomere DNA lengths were
also tested in a mixed linear model against characteristics of
morphology, including cell number, fragmentation rate, and
embryo grade. Tests were performed with R’s nlme package
[34,35]. Telomere results were analyzed blind to aneuploidy status
and vice-versa.
Aneuploidy assignments were based on the use of a previously
published method involving single nucleotide polymorphism (SNP)
microarray based copy number analysis [2]. This method has had
preclinical validation performed on randomized and blinded single
cells from cell lines with previously well characterized aneuploid
karyotypes, demonstrating 98.6% accuracy and no false positive
aneuploidy diagnoses [2]. It has also had clinical validation
performed through a prospective randomized non-selection clinical
trial demonstrating 100% negative predictive value for the
reproductive potential of human embryos [3]. SNP microarray
data described in this study have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO Series
accession number GSE25864 (http://www.ncbi.nlm.nih.gov/geo).
Evaluation of putative mechanisms of telomere DNA
normalization in blastocysts with aneuploidy
Twenty one sets of samples including the 1
st polar body, 2
nd
polar body, and blastomere derived from the same oocyte, and 29
sets of samples inluding the 1
st polar body, 2
nd polar body, and
trophectoderm, were evaluated. All samples were included on the
basis of chromosomal normalcy as predicted using SNP micro-
array based analysis described above. Quantities of telomere DNA
in the 2
nd polar bodies, blastomeres, and trophectoderm were
calculated relative to the corresponding first polar body from the
same original oocyte. Forty four embryos that arrested at
developmental stages equivalent to 44 developmentally competent
sibling embryos were evaluated. Quantities of telomere DNA in
arrested embryos were calculated relative to the developmentally
competent embryos.
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